Skip to main content
CTEV
NYSE Trade & Services

Claritev Reports Increased Q1 Net Loss, Higher Cash Burn, and Significant CEO Compensation Package

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$24.21
Mkt Cap
$410.769M
52W Low
$12.04
52W High
$74.07
52W Position info
101% above low
Off High info
67% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

CTEV has more than doubled off its 52-week low of $12.04.

Summary

Claritev Corp reported an increased net loss of $73.56 million and higher cash used in operations for Q1 2026, alongside a significant $9 million equity grant and increased bonus target for its CEO.


Key Events · Earnings and Guidance · CTEV

  • Increased Net Loss

    Net loss rose to $73.56 million ($4.41 per share) in Q1 2026, compared to $71.32 million ($4.38 per share) in Q1 2025. This follows the 8-K and news announcement earlier today.

  • Higher Cash Burn from Operations

    Net cash used in operating activities increased significantly to $45.78 million in Q1 2026 from $30.06 million in Q1 2025.

  • Significant CEO Compensation

    CEO Travis S. Dalton received a $9 million equity grant for 2026 ($6.75M time-based RSUs, $2.25M performance-based RSUs) and an increased target bonus of 150% of earned base salary.

  • Persistent Material Weakness

    The material weakness in internal controls over financial reporting, previously disclosed in the 2025 10-K, remains unremediated as of March 31, 2026.


Analysis · CTEV · Trade & Services

Claritev Corp's first-quarter 2026 results show a concerning trend of increasing net losses and a substantial rise in cash used for operating activities, indicating a worsening cash burn. While the company achieved modest revenue and Adjusted EBITDA growth, this was overshadowed by a significant increase in interest expense and general and administrative costs, including legal expenses related to antitrust matters. The disclosure of a $9 million equity grant and a 150% target bonus for the CEO, in the context of these losses and persistent material weaknesses in internal controls, is likely to draw investor scrutiny regarding executive compensation alignment with company performance. The continued unremediated material weakness in IT general controls also highlights ongoing operational risks. Investors should monitor the company's cash runway and the effectiveness of its remediation efforts for internal controls.

At the time of this filing, CTEV was trading at $24.21 on NYSE in the Trade & Services sector, with a market capitalization of approximately $410.8M. The 52-week trading range was $12.04 to $74.07. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTEV - Latest Insights

CTEV
Jul 30, 2026, 9:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $23.40
Real-time Price: $22.71 info
Change: -$0.690 (-3%) info
Market Cap: $387.155M info
CTEV
Jun 22, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $28.77
Real-time Price: $22.71 info
Change: -$6.06 (-21%) info
Market Cap: $387.155M info
CTEV
Jun 22, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $28.44
Real-time Price: $22.71 info
Change: -$5.73 (-20%) info
Market Cap: $387.155M info
CTEV
May 18, 2026, 12:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.71
Real-time Price: $22.71 info
Change: +$11.00 (+94%) info
Market Cap: $387.155M info
CTEV
May 07, 2026, 6:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.47
Real-time Price: $22.71 info
Change: -$3.76 (-14%) info
Market Cap: $387.155M info